erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Weight Gain D015430 101 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Pain D010146 64 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Psoriasis D011565 47 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia P388 D007941 43 associated lipids
Arthritis D001168 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Hypotension D007022 41 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Heart Failure D006333 36 associated lipids
Acne Vulgaris D000152 35 associated lipids
Glomerulonephritis D005921 35 associated lipids
Epilepsy D004827 35 associated lipids
Fever D005334 35 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Uremia D014511 33 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Diarrhea D003967 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Liver Diseases D008107 31 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis D003872 30 associated lipids
Obesity D009765 29 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Nasal Polyps D009298 26 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cholestasis D002779 23 associated lipids
Birth Weight D001724 23 associated lipids
Hypersensitivity D006967 22 associated lipids
Periodontitis D010518 22 associated lipids
Vomiting D014839 21 associated lipids
Bacterial Infections D001424 21 associated lipids
Pleurisy D010998 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Tuberculosis D014376 20 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Ataxia D001259 20 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Hypothermia D007035 19 associated lipids
Leishmaniasis D007896 19 associated lipids
Ischemia D007511 18 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Cholelithiasis D002769 16 associated lipids
Choline Deficiency D002796 16 associated lipids
Blister D001768 16 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Synovitis D013585 15 associated lipids
Tremor D014202 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Neutropenia D009503 15 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Stomatitis D013280 14 associated lipids
Uveitis D014605 14 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Campylobacter Infections D002169 13 associated lipids
Airway Obstruction D000402 13 associated lipids
Pain, Postoperative D010149 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Bradycardia D001919 13 associated lipids
Urticaria D014581 13 associated lipids
Critical Illness D016638 13 associated lipids
Hematuria D006417 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Abscess D000038 13 associated lipids
Multiple Myeloma D009101 13 associated lipids
Rosacea D012393 13 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Van Herwaarden MA et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. 2000 Aliment. Pharmacol. Ther. pmid:10759625
Ramirez B and Richter JE Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. 1993 Aliment. Pharmacol. Ther. pmid:8094981
Catnach SM et al. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. 1993 Aliment. Pharmacol. Ther. pmid:8439638
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Haans JJ and Masclee AA Review article: The diagnosis and management of gastroparesis. 2007 Aliment. Pharmacol. Ther. pmid:18081647
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Emmanuel AV et al. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. 2004 Aliment. Pharmacol. Ther. pmid:15023171
Netzer P et al. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:12182748
Athanasakis E et al. Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. 2002 Aliment. Pharmacol. Ther. pmid:12182757
McCallum RW and Cynshi O Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. 2007 Aliment. Pharmacol. Ther. pmid:17894654
Winstead NS and Wilcox CM Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. 2007 Aliment. Pharmacol. Ther. pmid:17848180
Bell GD et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. 1992 Aliment. Pharmacol. Ther. pmid:1486161
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Annese V et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. 1997 Aliment. Pharmacol. Ther. pmid:9218089
van Erpecum KJ et al. Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. 2000 Aliment. Pharmacol. Ther. pmid:10903008
Chiba T et al. Motilides accelerate regional gastrointestinal transit in the dog. 2000 Aliment. Pharmacol. Ther. pmid:10886053
Minocha A et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. 1995 Aliment. Pharmacol. Ther. pmid:8580273
Landry C et al. Could oral erythromycin optimize high energy continuous enteral nutrition? 1996 Aliment. Pharmacol. Ther. pmid:8971296
Jameson JS et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. 1992 Aliment. Pharmacol. Ther. pmid:1420750
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Kendall BJ et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9146779
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs. 2004 AIDS Treat News pmid:15595151
Schlecht HP et al. Images in HIV/AIDS. HIV-associated lymphogranuloma venereum proctitis. 2007 AIDS Read pmid:17396331
Berger TG and Koehler JE Bacillary angiomatosis. 1993-1994 AIDS Clin Rev pmid:8217903
van der Wouw PA et al. Disseminated cat-scratch disease in a patient with AIDS. 1989 AIDS pmid:2515881
Taha TE et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. 2006 AIDS pmid:16816561
Takei M et al. [Studies on the mixed culture of Candida and Lactobacillus. 3. Influences of the antibiotics (EM and TM)]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5236280
Sugiyama H [Experimental studies on control of dental caries. 1. Preventive effect of Erythromycin]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5244796
Sugiyama H [Experimental studies on control of dental caries. 2. Erythromycin and oral microbial flora]. 1968 Aichi Gakuin Daigaku Shigakkai Shi pmid:5261349
Chen SZ et al. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. 2005 Ai Zheng pmid:16086867
Hashiba H et al. Transformation of Lactobacillus helveticus subsp. jugurti with plasmid pLHR by electroporation. 1990 Agric. Biol. Chem. pmid:1368569
LIGNY G and VIGUIE R [DESTRUCTION OF THE INTESTINAL FLORA BY ANTIBIOTIC THERAPY]. 1964 May-Jun Agressologie pmid:14185522
Friedman GD and Selby JV Epidemiological screening for potentially carcinogenic drugs. 1990 Agents Actions Suppl. pmid:2316434
Carević O and Djokić S Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. 1988 Agents Actions pmid:2847507
Campbell G et al. A cautionary tale: delayed onset rhabdomyolysis due to erythromycin/simvastatin interaction. 2007 Age Ageing pmid:17913761
Haboubi NY et al. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. 1991 Age Ageing pmid:2028847
Roddis MJ Antibiotic-associated colitis: a retrospective study of fifteen cases. 1978 Age Ageing pmid:101026
Olatunji FO et al. Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria. 2007 Afr J Med Med Sci pmid:18390064